FDA grants East Bay biotech emergency approval of Covid antibody tests

The U.S. Food and Drug Administration allowed emergency use authorization to a Hercules-based biotech for a coronavirus antibody test. Bio-Rad Laboratories (NYSE: BIO) becomes the first Bay Area company to receive an authorization for an antibody test from the FDA, according to the FDA's website, though nine other antibody tests have been granted similar authorization to companies outside the region. The FDA limited the tests to authorized laboratories. As our senior biotech writer Ron Leuty recently?

Click to view original post